According to the latest report published by Data Bridge Market Research, the Europe Angioplasty Balloons Market
CAGR Value
- The Europe angioplasty balloons market size was valued at USD 795.22 million in 2025 and is expected to reach USD 874.84 million by 2033, at a CAGR of 1.2% during the forecast period
All the statistical data including facts and figures that are included in the trustworthy Europe Angioplasty Balloons Market report is represented by using several charts, graphs or tables. This market report gives an analytical estimation of the most important challenges that may appear in the market with respect to sales, export/import, or revenue. The business report describes estimations about key players and brands in the market with respect to their actions such as developments, product launches, acquisitions, mergers, joint ventures and competitive research. The report is mainly delivered in the form of PDF and spreadsheets while PPT can also be provided depending upon client’s request. Europe Angioplasty Balloons Market is a promising, client-centric, and consistent market research report which accomplishes client’s business needs.
Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/europe-angioplasty-balloons-market
Europe Angioplasty Balloons Market Segmentation and Market Companies
Segments
- By Product Type: Drug-Coated Balloons, Normal Balloons
- By Material: Nylon, Polyurethane
- By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
The Europe Angioplasty Balloons market is segmented based on product type, material, and end-user. The product type segment includes drug-coated balloons and normal balloons. Drug-coated balloons have gained popularity due to their ability to deliver medication directly to the affected area, reducing the risk of restenosis. Normal balloons remain a staple in angioplasty procedures, providing mechanical dilation of the blood vessels. In terms of material, angioplasty balloons are made from nylon or polyurethane. Nylon balloons are known for their durability and flexibility, while polyurethane balloons offer excellent trackability and pushability. Finally, the end-user segment comprises hospitals, specialty clinics, and ambulatory surgical centers. Hospitals are the largest end-user due to the high volume of angioplasty procedures performed in these settings, followed by specialty clinics and ambulatory surgical centers.
Market Players
- Medtronic
- Boston Scientific Corporation
- Abbott
- B. Braun Melsungen AG
- Cook
- Cardinal Health
- Terumo Corporation
- C. R. Bard, Inc.
- Biotronik
- Spectranetics (A Subsidiary of Koninklijke Philips N.V.)
Key players in the Europe Angioplasty Balloons market include Medtronic, Boston Scientific Corporation, Abbott, B. Braun Melsungen AG, Cook, Cardinal Health, Terumo Corporation, C. R. Bard, Inc., Biotronik, and Spectranetics. These companies are at the forefront of developing innovative angioplasty balloon technologies and expanding their market presence through strategic partnerships and acquisitions. Medtronic, for example, offers a comprehensive portfolio of angioplasty balloons for various clinical applications, solidifying its position as a market leader. Boston Scientific Corporation is known for its expertise in drug-coated balloons, driving advancements in targeted drug delivery for improved patient outcomes. Abbott focuses on developing next-generation angioplasty balloons that enhance procedural success rates and patient safety. B. Braun Melsungen AG and Cook are also prominent players in the market, leveraging their extensive experience in medical devices to address the growing demand for angioplasty solutions. Collaborations between these market players are expected to further accelerate market growth and innovation in the Europe Angioplasty Balloons industry.
The Europe Angioplasty Balloons market is witnessing significant growth driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements in angioplasty balloon therapies, and the rising adoption of minimally invasive procedures. As the aging population in Europe continues to grow, there is a higher incidence of coronary artery disease, leading to a greater demand for angioplasty procedures using balloons. Moreover, the shift towards outpatient settings such as specialty clinics and ambulatory surgical centers for angioplasty treatments is enhancing patient convenience and reducing healthcare costs, further fueling market expansion.
In terms of product segmentation, the demand for drug-coated balloons is expected to witness substantial growth due to their targeted drug delivery mechanisms that help prevent restenosis and improve long-term outcomes for patients. Normal balloons, on the other hand, remain widely used for mechanical dilation during angioplasty procedures, offering cost-effective and efficient solutions for vessel revascularization. The choice of material for angioplasty balloons, whether nylon or polyurethane, is influenced by factors such as durability, flexibility, trackability, and pushability, catering to the diverse needs of healthcare providers and patients.
Key market players such as Medtronic, Boston Scientific Corporation, and Abbott are investing heavily in research and development to introduce advanced angioplasty balloon technologies that enhance procedural success rates and patient safety. These companies are focusing on strategic collaborations and acquisitions to expand their product portfolios and geographic presence in the Europe Angioplasty Balloons market. The competitive landscape is characterized by intense rivalry and a strong emphasis on innovation and product differentiation to gain a competitive edge.
The Europe Angioplasty Balloons market is poised for continued growth, driven by factors such as technological advancements, increasing healthcare expenditure, and a growing awareness of minimally invasive treatment options among patients and healthcare providers. Market players will need to adapt to changing market dynamics, regulatory requirements, and patient preferences to sustain growth and maintain their competitive position in the evolving landscape of angioplasty balloon therapies in Europe. Continued investment in research and development, strategic collaborations, and a focus on market expansion will be crucial for companies to capitalize on emerging opportunities and address the evolving needs of the healthcare industry.The Europe Angioplasty Balloons market is witnessing robust growth driven by several key factors. The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, is a major driver of market expansion. With the aging population in Europe on the rise, there is a higher incidence of cardiovascular conditions, leading to an increased demand for angioplasty procedures utilizing balloons. Furthermore, technological advancements in angioplasty balloon therapies, such as the development of drug-coated balloons for targeted drug delivery, are enhancing treatment outcomes and reducing the risk of restenosis. These innovations are crucial in improving patient safety and procedural success rates.
The market is also seeing a shift towards outpatient settings like specialty clinics and ambulatory surgical centers for angioplasty procedures. This trend is driven by the desire for enhanced patient convenience and reduced healthcare costs, which is further propelling market growth. The demand for drug-coated balloons is expected to experience substantial growth due to their ability to prevent restenosis and improve long-term patient outcomes. Normal balloons, which are cost-effective and efficient for mechanical dilation, continue to be widely utilized in angioplasty procedures. The choice of material for angioplasty balloons, whether nylon or polyurethane, is influenced by various factors such as durability, flexibility, trackability, and pushability, catering to the diverse needs of healthcare providers and patients.
Key market players such as Medtronic, Boston Scientific Corporation, and Abbott are heavily investing in research and development to introduce advanced technologies in angioplasty balloons that enhance procedural success rates and patient safety. Strategic collaborations and acquisitions are a significant focus for these companies to expand their product portfolios and geographic presence in the Europe Angioplasty Balloons market. The competitive landscape is characterized by intense rivalry, with a strong emphasis on innovation and product differentiation to gain a competitive advantage.
Looking ahead, the Europe Angioplasty Balloons market is poised for continued growth, driven by technological advancements, increasing healthcare expenditure, and a growing awareness of minimally invasive treatment options among patients and healthcare providers. Market players will need to adapt to changing market dynamics and regulatory requirements, as well as address evolving patient preferences, to sustain growth and maintain a competitive position in the market. Continued investment in research and development, strategic collaborations, and a focus on market expansion will be key strategies for companies to capitalize on emerging opportunities in the evolving landscape of angioplasty balloon therapies in Europe.
Learn about the company’s position within the industry
https://www.databridgemarketresearch.com/reports/europe-angioplasty-balloons-market/companies
Frequently Asked Questions About This Report
Which distribution channel leads the global Europe Angioplasty Balloons Market?
What is the impact of Mass Migration on Europe Angioplasty Balloons Market demand?
What are the trade barriers affecting the Europe Angioplasty Balloons Market in [Specific Region]?
What are the top 5 risks facing the global Europe Angioplasty Balloons Market?
Which untapped markets offer the best potential for Europe Angioplasty Balloons Market expansion?
What are the key technology players in the Europe Angioplasty Balloons Market?
How are companies building Antifragility in the Europe Angioplasty Balloons Market?
How do import/export policies impact the Europe Angioplasty Balloons Market?
What is the carbon intensity of Europe Angioplasty Balloons Market production?
How is the Europe Angioplasty Balloons Market evolving in terms of packaging and delivery?
What are the legal barriers to entry in the Europe Angioplasty Balloons Market?
Browse More Reports:
Global Medical Robotic System Market
Global Medical Transcription Market
Global Mitogen-Activated ERK Kinase (MEK) Inhibitors Market
Global Metallic Stearates Market
Global Methylene Diphenyl Di-Isocyanate (MDI) Market
Global Mineral Wool Market
Global Mycotoxin Binders Market
Global Neem Extracts Market
Global Network Slicing Market
Global Neurovascular Embolization Devices Market
Global Oilseeds Market
Global Omega 3 for Food Ingredients Market
Global Online Membership Software Market
Global Ophthalmology Lasers Market
Global Organic Meat Products Market
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 999
Email:- [email protected]